Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Type III hyperlipoproteinemia associated with apolipoprotein E deficiency.

G Ghiselli, E J Schaefer, P Gascon

    Science (New York, N.Y.)
    |December 11, 1981
    PubMed
    Summary

    Type III hyperlipoproteinemia, characterized by high cholesterol and premature atherosclerosis, may stem from a deficiency in apolipoprotein E. This study describes a family lacking detectable apolipoprotein E, supporting this hypothesis.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Brimonidine and acute anterior granulomatous uveitis: A case report and literature review].

    Journal francais d'ophtalmologie·2017
    Same author

    Predictive modeling of the outcomes of chemotherapy-induced (febrile) neutropenia prophylaxis with biosimilar filgrastim (MONITOR-GCSF study).

    Annals of oncology : official journal of the European Society for Medical Oncology·2016
    Same author

    European edition of the NCCN clinical practice guidelines: relevance of the translation and adaptation into Spanish.

    Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2016
    Same author

    [Eplerenone treatment in chronic central serous chorioretinopathy].

    Journal francais d'ophtalmologie·2016
    Same author

    Sequential treatment with immunotherapy and BRAF inhibitors in BRAF-mutant advanced melanoma.

    Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2016
    Same author

    [Retinal arterial macroaneurysms with intraretinal exudates].

    Journal francais d'ophtalmologie·2015

    Area of Science:

    • Biochemistry
    • Genetics
    • Cardiovascular Medicine

    Background:

    • Type III hyperlipoproteinemia is linked to elevated cholesterol and premature atherosclerosis.
    • This condition involves abnormal very low-density lipoproteins (VLDL) and impaired hepatic uptake of lipoproteins.
    • Apolipoprotein E is a key protein in VLDL, crucial for lipoprotein metabolism.

    Purpose of the Study:

    • To investigate the role of apolipoprotein E deficiency in type III hyperlipoproteinemia.
    • To describe a novel family exhibiting characteristics of type III hyperlipoproteinemia.

    Main Methods:

    • Analysis of patient plasma for apolipoprotein E levels.
    • Characterization of a new kindred with type III hyperlipoproteinemia.

    Related Experiment Videos

    Main Results:

    • No detectable plasma apolipoprotein E was found in the described kindred.
    • This finding aligns with the proposed link between apolipoprotein E absence and type III hyperlipoproteinemia.

    Conclusions:

    • Absence or severe deficiency of apolipoprotein E is a likely cause of type III hyperlipoproteinemia.
    • Further research into apolipoprotein E's role in lipoprotein disorders is warranted.